Short Course of Empirical Gentamicin in Patients With Severe Sepsis and Septic Shock in the ICU: A Benefit or a Burden?
Clin Infect Dis
.
2017 Sep 1;65(5):873-874.
doi: 10.1093/cid/cix447.
Authors
Maarten Cobussen
1
,
Thomas Havenith
2
,
Dirk Posthouwer
3
,
Frank H van Tiel
1
,
Patricia M Stassen
3
,
Michiel B Haeseker
1
Affiliations
1
Departments of Medical Microbiology, Maastricht University Medical Center, The Netherlands.
2
Clinical Pharmacy, Maastricht University Medical Center, The Netherlands.
3
Internal Medicine, Maastricht University Medical Center, The Netherlands.
PMID:
29017277
DOI:
10.1093/cid/cix447
No abstract available
Publication types
Letter
Comment
MeSH terms
Cohort Studies
Gentamicins
Humans
Intensive Care Units
Prospective Studies
Sepsis*
Shock, Septic*
Substances
Gentamicins